Scinai Immunotherapeutics Ltd News - SCNI

Golden Valley Development, Inc. Announces Appointment of Top Toxicologist and Medical Device Scientist to Advisory Board

Golden Valley Development, Inc. Announces Appointment of Top Toxicologist and Medical Device Scientist to Advisory Board PR Newswire CLEARWATER...

Golden Valley Development, Inc. Announces Contract to Produce Final Percuguard Medical Device Prototype

Golden Valley Development, Inc. (OTC: GVDI) (www.goldenvalleydev.com) is pleased to announce the signing of top plastics design...

Golden Valley Development, Inc. Announces Appointment of Leading Business Consultant to Advisory Board

Golden Valley Development, Inc. (OTC:GVDI) (www.goldenvalleydev.com) is pleased to announce the appointment of David Sanders to...

GVDI Announces Re-launching of Website With New Information Made Available to Public

Golden Valley Development, Inc. (Other-OTC: GVDI) (www.goldenvalleydev.com) announces the re-launching of its website including...

GVDI Holds Patents on New Solution to Healthcare Workers’ Risk

Golden Valley Development, Inc. (Other-OTC: GVDI) (www.goldenvalleydev.com) is pleased to announce the development of the...

Golden Valley Development, Inc. Announces Appointment of Leading Dental Materials Scientist to Advisory Board

Golden Valley Development, Inc. (OTC: GVDI) (www.goldenvalleydev.com) is pleased to announce the appointment of John Powers, Ph...

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF...

Golden Valley Development, Inc. Announces Acquisition of Two Companies

Golden Valley Development, Inc. (OTC:GVDI) is pleased to announce that it has recently completed the acquisition of two new...

Golden Valley Development, Inc. Clarifies Its Web Presence

Golden Valley Development, Inc. (OTC: GVDI), a Bakersfield-based intermediary finder of fresh produce and live animals for...

- Withdrawal of Registration Statement (RW)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x ...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERL...

- Amended Annual Report (10-K/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A ANNUAL REPORT UNDER SECTION 13 OF THE...

- Annual Report (10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A ANNUAL REPORT UNDER SECTION 13 OF THE...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUART...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Scinai Immunotherapeutics Ltd (SCNI)

Professional-Grade Tools, for Individual Investors.

SCNI News

Golden Valley Development, Inc. Announces Appointment of Top Toxicologist and Medical Device Scientist to Advisory Board

Golden Valley Development, Inc. Announces Contract to Produce Final Percuguard Medical Device Prototype

Golden Valley Development, Inc. Announces Appointment of Leading Business Consultant to Advisory Board

GVDI Announces Re-launching of Website With New Information Made Available to Public

GVDI Holds Patents on New Solution to Healthcare Workers’ Risk

Golden Valley Development, Inc. Announces Appointment of Leading Dental Materials Scientist to Advisory Board

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

Golden Valley Development, Inc. Announces Acquisition of Two Companies

Golden Valley Development, Inc. Clarifies Its Web Presence

- Withdrawal of Registration Statement (RW)

- Quarterly Report (10-Q)

- Quarterly Report (10-Q)

- Amended Annual Report (10-K/A)

- Annual Report (10-K)

- Quarterly Report (10-Q)

SCNI Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Scinai Immunotherapeutics Ltd (SCNI) News

Scinai Immunotherapeutics Ltd (SCNI)

Professional-Grade Tools, for Individual Investors.

SCNI News

Golden Valley Development, Inc. Announces Appointment of Top Toxicologist and Medical Device Scientist to Advisory Board

Golden Valley Development, Inc. Announces Contract to Produce Final Percuguard Medical Device Prototype

Golden Valley Development, Inc. Announces Appointment of Leading Business Consultant to Advisory Board

GVDI Announces Re-launching of Website With New Information Made Available to Public

GVDI Holds Patents on New Solution to Healthcare Workers’ Risk

Golden Valley Development, Inc. Announces Appointment of Leading Dental Materials Scientist to Advisory Board

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

Golden Valley Development, Inc. Announces Acquisition of Two Companies

Golden Valley Development, Inc. Clarifies Its Web Presence

- Withdrawal of Registration Statement (RW)

- Quarterly Report (10-Q)

- Quarterly Report (10-Q)

- Amended Annual Report (10-K/A)

- Annual Report (10-K)

- Quarterly Report (10-Q)

SCNI Discussion

Your Recent History